117
Views
6
CrossRef citations to date
0
Altmetric
Uveitis

Ubiquitin Associated and SH3 Domain Containing B (UBASH3B) Gene Association with Behcet’s Disease in Iranian Population

, , , , &
Pages 200-205 | Received 03 Mar 2018, Accepted 12 Sep 2018, Published online: 22 Oct 2018

References

  • Jennette JC, Falk R, Bacon P, Basu N, Cid M, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11. doi:10.1002/art.37715.
  • Verity D, Marr J, Ohno S, Wallace G, Stanford M. Behçet’s disease, the silk road and HLA‐B51: historical and geographical perspectives. Tissue Antigens. 1999;54(3):213–20.
  • Keino H, Okada AA. Behcet’s disease: global epidemiology of an old silk road disease. Br J Ophthalmol. 2007;91(12):1573–74. doi:10.1136/bjo.2007.124875.
  • Kim S-K, Jang W-C, Ahn Y-C, Lee S-H, Lee -S-S, Hur J-W. Promoter–2518 single nucleotide polymorphism of monocyte chemoattractant protein-1 is associated with clinical severity in Behçet’s disease. Inflamm Res. 2012;61(6):541–45. doi:10.1007/s00011-012-0471-5.
  • Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med. 1999;341(17):1284–91. doi:10.1056/NEJM199910213411707.
  • Marshall SE. Behçet’s disease. Best Pract Res Clin Rheumatol. 2004;18(3):291–311. doi:10.1016/j.berh.2004.02.008.
  • Mohammad A, Mandl T, Sturfelt G, Segelmark M. Incidence, prevalence and clinical characteristics of Behcet’s disease in southern Sweden. Rheumatology (Oxford). 2012;52(2):304–10. doi:10.1093/rheumatology/kes249.
  • Mendes D, Correia M, Barbedo M, Vaio T, Mota M, Gonçalves O, Valente J. Behçet’s disease–a contemporary review. J Autoimmun. 2009;32(3):178–88. doi:10.1016/j.jaut.2009.02.011.
  • Paovic J, Paovic P, Sredovic V. Behcet’s disease: systemic and ocular manifestations. Biomed Res Int. 2013:2013. doi:10.1155/2013/247345.
  • Weichsler B, Davatchi F, Mizushima Y, Hamza M, Dilsen N, Kansu E, Yazici H, Barnes CG, Chamberlain MA, James DG, et al. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335(8697):1078–80. doi:10.1016/0140-6736(90)92643-V.
  • Nanthapisal S, Klein NJ, Ambrose N, Eleftheriou D, Brogan PA. Paediatric Behçet’s disease: a UK tertiary centre experience. Clin Rheumatol. 2016;35(10):2509–16. doi:10.1007/s10067-016-3187-z.
  • Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol. 2005;50(4):297–350. doi:10.1016/j.survophthal.2005.04.009.
  • Abdolmohammadi R, Bonyadi M. Polymorphisms of promoter region of TNF-α gene in Iranian Azeri Turkish patients with Behçet’s disease. J Korean Med Sci. 2017;32(1):33–37. doi:10.3346/jkms.2017.32.1.33.
  • Hu H, Sun S-C. Ubiquitin signaling in immune responses. Cell Res. 2016;26(4):457–83. doi:10.1038/cr.2016.40.
  • Husnjak K, Dikic I. Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu Rev Biochem. 2012;81:291–322. doi:10.1146/annurev-biochem-051810-094654.
  • Singer AL, Koretzky GA. Control of T cell function by positive and negative regulators. Science. 2002;296(5573):1639–40. doi:10.1126/science.1071551.
  • Carpino N, Chen Y, Nassar N, Oh H-W. The Sts proteins target tyrosine phosphorylated, ubiquitinated proteins within TCR signaling pathways. Mol Immunol. 2009;46(16):3224–31. doi:10.1016/j.molimm.2009.08.015.
  • Fei Y, Webb R, Cobb BL, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH. Identification of novel genetic susceptibility loci for Behçet’s disease using a genome-wide association study. Arthritis Res Ther. 2009;11(3):R66. doi:10.1186/ar2695.
  • Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. doi:10.1093/nar/16.3.1215.
  • Yabuki K, Mizuki N, Ota M, Katsuyama Y, Palimeris G, Stavropoulos C, Koumantaki Y, Spyropoulou M, Giziaki E, Kaklamani V, et al. Association of MICA gene and HLA-B* 5101 with Behcet’s disease in Greece. Invest Ophthalmol Vis Sci. 1999;40(9):1921–26.
  • Mizuki N, Yabuki K, Ota M, Katsuyama Y, Ando H, Nomura E, Funakoshi K, Davatchi F, Chams H, Nikbin B, et al. Analysis of microsatellite polymorphism around the HLA‐B locus in Iranian patients with Behçet’s disease. Tissue Antigens. 2002;60(5):396–99.
  • Benezra D, Cohen E. Treatment and visual prognosis in Behçet’s disease. Br J Ophthalmol. 1986;70(8):589–92.
  • Tugal-Tutkun I. Behçet’s uveitis. Middle East Afr J Ophthalmol. 2009;16(4):219. doi:10.4103/0974-9233.58425.
  • Hou S, Qi J, Zhang Q, Liao D, Li Q, Hu K, Zhou Y, Kijlstra A, Yang P. Genetic variants in the JAK1 gene confer higher risk of Behcet’s disease with ocular involvement in Han Chinese. Hum Genet. 2013;132(9):1049–58. doi:10.1007/s00439-013-1312-5.
  • Mikhailik A, Ford B, Keller J, Chen Y, Nassar N, Carpino N. A phosphatase activity of Sts-1 contributes to the suppression of TCR signaling. Mol Cell. 2007;27(3):486–97. doi:10.1016/j.molcel.2007.06.015.
  • Luis BS, Carpino N. Insights into the suppressor of T‐cell receptor (TCR) signaling‐1 (Sts‐1)‐mediated regulation of TCR signaling through the use of novel substrate‐trapping Sts‐1 phosphatase variants. FEBS J. 2014;281(3):696–707. doi:10.1111/febs.12615.
  • Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen Z. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 2000;103(2):351–61. doi:10.1016/S0092-8674(00)00126-4.
  • Zhou H, Wertz I, O’rourke K, Ultsch M, Seshagiri S, Eby M, Xiao W, Dixit VM. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO. Nature. 2004;427(6970):167–71. doi:10.1038/nature02273.
  • Park G, Kim H-S, Choe J-Y, Kim S-K. SUMO4 C438T polymorphism is associated with papulopustular skin lesion in Korean patients with Behçet’s disease. Rheumatol Int. 2012;32(10):3031–37. doi:10.1007/s00296-011-2086-5.
  • Hou S, Yang P, Du L, Zhou H, Lin X, Liu X, Kijlstra A. SUMO4 gene polymorphisms in Chinese han patients with Behcet’s disease. Clin Immunol. 2008;129(1):170–75. doi:10.1016/j.clim.2008.06.006.
  • Kamoun M, Karray E, Zakraoui I. Association of small ubiquitin-like modifier 4 (SUMO4) polymorphisms in a Tunisian population with Behcet’s disease. Clin Exp Rheumatol. 2010;28(4):S45.
  • Hou S, Shu Q, Jiang Z, Chen Y, Li F, Chen F, Kijlstra A, Yang P. Replication study confirms the association between UBAC2 and Behçet’s disease in two independent Chinese sets of patients and controls. Arthritis Res Ther. 2012;14(2):R70. doi:10.1186/ar3789.
  • Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, Ito N, Kera J, Okada E, Yatsu K, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet’s disease susceptibility loci. Nat Genet. 2010;42(8):703–06. doi:10.1038/ng.624.
  • Hou S1, Yang Z, Du L, Jiang Z, Shu Q, Chen Y, Li F, Zhou Q, Ohno S, Chen R, et al. Identification of a susceptibility locus in STAT4 for Behçet’s disease in Han Chinese in a genome-wide association study. Arthritis Rheum. 2012;64(12):4104–13. doi:10.1002/art.37708.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.